Ascentage Pharma Group International

Yahoo Finance • 2 months ago

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates

Product sales from Olverembatinib in the first half of 2025 increased 93%year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to the expansion of NRDL coverageCommenced commercial sales of Lisaftoclax in China, foll... Full story

Yahoo Finance • 2 months ago

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization... Full story

Yahoo Finance • 2 months ago

Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025

ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet m... Full story

Yahoo Finance • 3 months ago

Ascentage Pharma’s Novel Cancer Drug Approved in China

Ascentage Pharma Group International (NASDAQ:AAPG) is one of the best young stocks to buy and hold for 5 years. On July 10, Ascentage Pharma announced that China’s National Medical Products Administration/NMPA approved its novel Bcl-2 sele... Full story

Yahoo Finance • 3 months ago

Ascentage Pharma announces $192.3 million share placement

ROCKVILLE, Md. and SUZHOU, China - Ascentage Pharma Group International Inc. (NASDAQ:AAPG; HKEX:6855), which has seen its stock surge 120% over the past year according to InvestingPro data, announced Monday the pricing of 22 million ordina... Full story

Yahoo Finance • 3 months ago

Ascentage Pharma Names CFO & SVP of Global Corporate Development & Finance

By Karen Roman Ascentage Pharma Group International (Nasdaq: AAPG) said it designated Veet Misra, Ph.D., as Chief Financial Officer, and Eric Huang as Senior Vice President of Global Corporate Development and Finance. Dr. Misra has more... Full story

Yahoo Finance • 5 months ago

Is Ascentage Pharma (AAPG) the Best Performing Healthcare Stock to Buy Now?

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where Ascentage Pharma Group Internat (NASDAQ:AAPG) stands against other best performing healthcare stocks to... Full story